Goldman Sachs Group »

Merrimack Pharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Merrimack Pharma shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $451k 30k 15.13
2024-03-31 $214k 15k 14.77
2023-12-31 $472k 35k 13.41
2023-09-30 $431k 35k 12.33
2023-06-30 $174k 14k 12.30
2023-03-31 $429k 35k 12.29
2022-12-31 $162k 14k 11.46
2022-06-30 $84k 14k 5.94
2019-03-31 $184k 26k 6.97
2018-12-31 $102k 27k 3.85
2018-09-30 $387k 73k 5.32
2018-06-30 $669k 136k 4.91
2018-03-31 $232k 29k 8.04
2017-12-31 $396k 39k 10.24
2017-09-30 $1.6M 109k 14.54

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Merrimack Pharma

JBF Capital
Goldman Sachs Group
Rise Advisors
Farther Finance Advisors

View all funds holding Merrimack Pharma